MHRA Drug Safety Update: April 2024
A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 9 April 2024) has been published and includes articles on: Finasteride: reminder of the risk of psychiatric side effects and of sexual side effects (which may persist after discontinuation of treatment) Montelukast: reminder of the risk of neuropsychiatric reactions Letters [...]
The post MHRA Drug Safety Update: April 2024 appeared first on Community Pharmacy England.
Recent Comments